News & Publications

Representation of Icon Group Ltd. (iDigital) in an acquisition agreement of the control of VISUAL D.G. Ltd.

An iconic acquisition! Congrats to our client, Icon Group Ltd. (iDigital), for entering into an acquisition agreement of the control of VISUAL D.G. Ltd. at a company value of approx. NIS 80 million, according to media reports. VISUAL specializes in providing advanced software and computing solutions and is the official representative of the industry’s leading […]

Sharon Klein-Manbar & Raz Tepper & Ziv Schwartz & Sharon Madel-Artzy & Amit Bechler & Hila Karmona & Shahaf Kazelnik | Mar 2022 | Transaction

Representation of Sky Fund in the acquisition of 50% of the shares of Dolce Vita Way of Life Ltd.

La Dolce Vita Way of Life Congratulations to our client Sky Fund for the acquisition of 50% of the shares of Dolce Vita Way of Life Ltd. at a company value of approximately NIS 220 million, according to media reports. This is the first acquisition by Sky 4 Private Equity Fund, which just recently completed […]

Raz Tepper & Shmulik Fried & Ziv Schwartz & Omri Rachum-Twaig, Dr. & Ben Strauss & Hilla Sachs | Mar 2022 | Transaction

משרדנו ייצג את שותפות “פרויקט גולדמן 3 תל אביב” בהתקשרותה בהסכם מימון בהיקף של כ- 150 מיליון ש”ח, לצורך הקמת פרויקט יוקרה למגורים, מסחר ומלונאות, בהיקף של כ- 7,000 מ”ר. הפרויקט עתיד להיבנות ברחוב נחום גולדמן בתל אביב – יפו, על שפת הים ובסמיכות למתחם התחנה ומתחם שוק הפשפשים ביפו העתיקה.

משרדנו ייצג את אייקון גרופ בע”מ ואת בעלי מניותיה, קרן סקיי וקרן פיטנגו, בעסקה למכירת 20% ממניות החברה לפועלים שוקי הון, זרוע ההשקעות של בנק הפועלים, לפי שווי חברה של כ-350 מיליון ש”ח. העסקה כללה משא ומתן מורכב בין הצדדים ומימוש של זכות הצטרפות למכירה של בעלי המניות הנוספים בחברה. קבוצת אייקון גרופ היא יבואנית […]

Raz Tepper & Sharon Klein-Manbar | Nov 2020 | Transaction

Representation of Luminera Derm in the Sale of its Dermal Business to AbbVie

Representation of Luminera Derm Ltd. and its affiliated companies in a share and asset transaction, pursuant to which Luminera sold its dermal filler portfolio and R&D pipeline to AbbVie Inc. (NYSE: ABBV) unit Allergan Aesthetics, for a consideration of hundreds of millions of dollars. Luminera Derm is an R&D company as well as a manufacturer […]

Raz Tepper & Sharon Klein-Manbar & Ziv Schwartz & Sharona Haim Pour - Abramovich & Yuval Peled & Ben Strauss & Hila Zackay & Audrey Abensur & Moran Friedman | Oct 2020 | Transaction

Labor & Employment Legal Update – Bits & Briefs Series – August 2020

In this “Bits & Briefs” chapter of our special series dedicated to Labor and Employment Law, we discuss certain perspectives of engagement of consultants. Please find the full update here

Shay Teken & Moran Friedman & Raz Tepper & Eran Yaniv | Aug 2020 | Legal Update

FBC authored an article on Joint Ventures in the Israel-India Business Guide 2017

Click here to read the chapter written by FBC partners Eran Yaniv and Raz Tepper.

Raz Tepper & Eran Yaniv | May 2017 | Publication

Legal Update: 法律动态:跨国经营的考量—合营企业(中文)International Considerations-Joint Ventures

Please click below to read the full update (Chinese) 请点击这里阅读全文(中文  

Raz Tepper | Feb 2017 | Legal Update

FBC advises Globus Max in a NIS 80M loan agreement from Psagot

FBC advises the Globus Max cinema chain in a NIS 80M loan from the Psagot Investment House

Raz Tepper & Sharon Klein-Manbar | Nov 2014 | Transaction

FBC advises the OrbiMed Fund in an investment in AtoxBio

FBC advises Orbimed in an investment in Atox Bio, a clinical stage company which develops novel immune-modulators for severe infections.

Raz Tepper | Aug 2014 | Transaction

FBC advises Qualcomm in its acquisition of Wilocity for approximately $400M

FBC advises Qualcomm in its acquisition of Wilocity for approximately $400M

Raz Tepper & Moran Friedman | Jul 2014 | Transaction

FBC advises Qualcomm in its acquisition of CSR’s imaging unit for approximately $45M

FBC advises Qualcomm in its acquisition of CSR’s imaging unit for approximately $45M

Raz Tepper & Ronald Lehmann & Amit Dat & Moran Friedman & Ziv Schwartz | Jul 2014 | Transaction

FBC advises the OrbiMed Fund in an investment in Nucleix

FBC advises Orbimed in an investment in Nucleix, which develops a test for early detection of bladder cancer.

Raz Tepper | May 2014 | Transaction

FBC advises ThetaRay in a $1.25M investment by Poalim Ventures

FBC advises ThetaRay in a $1.25M investment by Poalim Ventures.

Raz Tepper | Feb 2014 | Transaction

FBC advises the OrbiMed Fund, in a $6M private placement transaction in RedHill Biopharma

FBC advises the OrbiMed Fund, in a $6M private placement transaction in RedHill Biopharma, a public company dually listed on the NASDAQ and TASE.

Raz Tepper | Dec 2013 | Transaction

FBC advises Perrigo in the Israeli aspects relating to the $8.6B acquisition of Elan Corporation and the reincorporation of Perrigo in Ireland

FBC advises Perrigo, a NYSE and TASE-traded company, in the Israeli aspects relating to the $8.6B acquisition of Elan Corporation and the reincorporation of Perrigo in Ireland.

Raz Tepper & Sharon Rosen & Sharon Klein-Manbar & Itiel Ben-Haim | Dec 2013 | Transaction

FBC advises the SKY Fund, in a NIS 15.1M transaction for the sale of its holdings in Elspec Engineering

FBC advises the SKY Fund, in a NIS 15.1M transaction for the sale of its holdings in Elspec Engineering, an Israeli publicly traded company.

Raz Tepper & Sharon Klein-Manbar | Dec 2013 | Transaction

FBC advises The Gores Group in a transaction with Imagine Communications

FBC advises The Gores Group and its portfolio company, HBC Soultions, in a transaction for the purchase of 100% of the shares of Imagine Communications.

Raz Tepper | Dec 2013 | Transaction

FBC represents Kamada in Israeli aspects related to its $60M Nasdaq IPO

FBC represents Kamada in Israeli aspects related to its $60M Nasdaq IPO

Raz Tepper & Ronald Lehmann & Sharon Rosen | May 2013 | Transaction

FBC advises Monsanto in investment in Evogene and acquisitions of Rosetta Green and the Beelogics group of companies

FBC advises Monsanto, in an investment in Evogene, a publicly traded Israeli company that develops genetic engineering technology, in its acquisition of Rosetta Green, a public Israeli company, and the Beelogics group of companies.

Hagar Keren-Hackim & Amit Dat & Itiel Ben-Haim & Ronald Lehmann & Raz Tepper & Ron Sitton | Feb 2013 | Transaction